Kairos 1C 1/2W


Hudson Structured backed SPAC Kairos Artemis article

Term = 24 months

Trust = $10.00. $200,000,000 or $230,000,000 if the underwriters’ over-allotment option is exercised in full will be deposited into a trust account at Citibank, with Continental Stock Transfer & Trust Company acting as trustee.


Cayman Islands


​New York, New York, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Kairos Acquisition Corp. (the “Company”) announced today the pricing of its initial public offering of 24,000,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Capital Market (the “Nasdaq”) and trade under the ticker symbol “KAIRU” beginning on January 6, 2021. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share. After the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “KAIR” and “KAIRW,” respectively. The offering is expected to close on January 8, 2021.

Kairos Acquisition Corp. is a blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue a business combination target in any business or industry, the Company intends to focus on regulated insurance or reinsurance companies, distributors or technology and insurance service providers that focus on specialty lines of business or that target product or customer niches. The Company is led by Chief Executive Officer, Peter Bang and Chief Financial Officer, Jerry de St. Paer.

Citigroup Global Markets Inc.  is acting as the sole-book running manager of the offering. I-Bankers Securities, Inc. is acting as the co-manager of the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 3,600,000 units at the initial public offering price to cover over-allotments, if any.